The G2 p38-Mediated Stress-Activated Checkpoint Pathway Becomes Attenuated in Transformed Cells

Current Biology

Volumn 17, Issue 24, 2007, Pages 2162-2168

  Mikhailov, Alexei ^a,b   Patel, Daksha ^c   McCance, Dennis J ^c   Rieder, Conly L ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CELLCYCLE; SIGNALING

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RAS PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL TRANSFORMATION; HELA CELL; HUMAN; METABOLISM; MITOSIS; PHYSIOLOGY; STRESS;

CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G2 PHASE; HELA CELLS; HUMANS; MITOSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; RETINOBLASTOMA PROTEIN; STRESS;

EID: 36849005121     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2007.11.028     Document Type: Article

References (30)

1. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., and Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78 (1994) 1027-1037
2. Michea L., Ferguson D.R., Peters E.M., Andrews P.M., Kirby M.R., and Burg M.B. Cell cylce delay and apoptosis are induced by high salt and urea in renal medullary cells. Am. J. Physiol. Renal Physiol. 278 (2000) F209-F218
3. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., Appella E., and Fornace A.J. Initiation of a G2/M checkpoint after ultraviolet radiation requries p38 kinase. Nature 411 (2001) 102-107
4. Dmitrieva N.I., Bulavin D.V., Fornace A.J., and Burg M.B. Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc. Natl. Acad. Sci. USA 99 (2002) 184-189
5. Zhang Y., Song S., Fong C.-C., Tsang C.-H., Yang Z., and Yang M. cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J. Invest. Dermatol. 120 (2003) 849-857
6. Bebien M., Salinas S., Becamel C., Richard V., Linares L., and Hipskind R.A. Immediate-early gene induction by the stresses anisomycin and arsenite in human osteosarcoma cells involves MAPK cascade signaling to Elk-1, CREB and SRF. Oncogene 22 (2003) 1836-1847
7. Bunyard P., Handley M., Pollara G., Rutault K., Wood I., Chaudry M., Alderman C., Foreman J., Katz D.R., and Chain B.M. Ribotoxic stress activates p38 and JNK kinases and modulates the antigen-presenting activity of dendritic cells. Mol. Immunol. 39 (2003) 815-827
8. Mikhailov A., Shinohara M., and Rieder C.L. The p38-mediated stress-activated checkpoint. Cell Cycle 4 (2005) 57-62
9. Grollman A.P. Inhibitors of protein biosynthesis. II Mode of action of anisomycin. J. Biol. Chem. 242 (1967) 3226-3233
10. Shu J., Hitomi M., and Stacey D. Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells. Oncogene 13 (1996) 2421-2430
11. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
12. 2/M transition in vertebrates. Curr. Biol. 10 (2000) 1067-1070
13. Ogawa T., Hayashi T., Kyoizumi S., Kusunoki Y., Nakachi K., MacPhee D.G., Trosko J.E., Kataoka K., and Yorioka N. Anisomycin downregulates gap-junctional intercellular communication via the P38 MAP-kinase pathway. J. Cell Sci. 117 (2004) 2087-2096
14. Cheung P.C.F., Campbell D.G., Nebreda A.R., and Cohen P. Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22 (2003) 5793-5805
15. Ungefroren H., Lenschow W., Chen W.B., Faendrich F., and Kalthoff H. Regulation of biglycan gene expression by transforming growth factor-β requires MKK6-p38 mitogen-activated protein kinase signaling downstream of Smad signaling. J. Biol. Chem. 278 (2003) 11041-11049
16. Aguirre-Ghiso J.A., Ossowski L., and Rosenbaum S.K. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 64 (2004) 7336-7345
17. Patel D., Incassati A., Wang N., and McCance D.J. Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M phase proteins. Cancer Res. 64 (2004) 1299-1306
18. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumor cells with defined genetic elements. Nature 400 (1999) 464-468
19. Deng Q., Liao R., Wu B.-L., and Sun P. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J. Biol. Chem. 279 (2004) 1050-1059
20. Schubbert S., Shannon K., and Bollag G. Hyperactive ras in developmental disorders and cancer. Nat. Rev. Cancer 7 (2007) 295-308
21. Benhar M., Dalyot I., Engelberg D., and Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-Terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21 (2001) 6913-6926
22. 2 DNA damage and mitotic spindle checkpoints. J. Biol. Chem. 281 (2006) 3800-3809
23. Saavedra H.I., Fukasawa K., Conn C.W., and Stambrook P.J. MAPK mediates RAS-induced chromosome instability. J. Biol. Chem. 274 (1999) 38083-38090
24. Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4 (2004) 937-947
25. Shinohara M., Mikhailov A.V., Aguirre-Ghiso J.A., and Rieder C.L. Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis. Mol. Biol. Cell 17 (2006) 5227-5240
26. Thuraisingam T., Xu Y.Z., Moisan J., Lachance C., Garnon J., Di Marco S., Gaestel M., and Radzioch D. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by toll-ike receptor 7 and 9 ligands. Mol. Immunol. 44 (2007) 3482-3491
27. Stoecklin G., Stubbs T., Kedersha N., Was S., Rigby W.F.C., Blackwell T.K., and Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23 (2004) 1313-1324
28. Reinhardt H.C., Aslanian A.S., Lees J.A., and Yaffe M.B. p53-deficient cells rely on ATM-and ATR-mediated checkpoint signaling through the p38MAP/MK2 pathway for survival after DNA damage. Cancer Cell 11 (2007) 175-189
29. Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E.H., and Yaffe M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition adn S phase progression in response to UV irradiation. Mol. Cell 17 (2005) 37-48
30. Cahill D.P., Kinzler K.W., Vogelstein B., and Lengauer C. Genetic instability and darwinian selection in tumors. Trends Cell Biol. 9 (1999) M57-M60